As previously reported on a Current Report on Form 8-K of Blue Whale Acquisition Corp I (the “Company”), on August 13, 2021, the Company consummated its initial public offering (the “IPO”) of 20,000,000 units (the “Units”). Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (an “Ordinary Share”), and one-fourth of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Ordinary Share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $200,000,000. The Company granted the underwriters of the IPO (the “Underwriters”) a 45-day option to purchase up to an additional 3,000,000 units at the IPO price to cover over-allotments, if any. On August 16, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,940,811 Units from the Company (the “Over-Allotment Units”), generating gross proceeds of $29,408,110 and resulting in the issuance of an additional 326,757 Class F ordinary shares and 653,513 Class G ordinary shares to the Company’s sponsor, Blue Whale Sponsor I LLC (the “Sponsor”).
As previously reported on a Current Report on Form 8-K of the Company, substantially concurrently with the closing of the IPO, the Company completed the private sale of 3,000,000 warrants (the “Private Placement Warrants”) at a purchase price of $2.00 per Private Placement Warrant, to the Sponsor, generating gross proceeds to the Company of $6,000,000. In connection with the Underwriters’ partial exercise of their over-allotment option, the Sponsor purchased an additional 294,081 Private Placement Warrants (the “Additional Private Placement Warrants”), generating gross proceeds to the Company of approximately $588,162.20.
In connection with the closing and sale of the Over-Allotment Units and the Additional Private Placement Warrants (together, the “Over-Allotment Closing”), a total of $29,408,110 in proceeds from the Over-Allotment Closing (which amount includes $1,029,283.85 of the Underwriters’ deferred discount) was placed in a U.S.-based trust account at JP Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee.
An audited balance sheet as of August 6, 2021 reflecting receipt of the proceeds upon consummation of the IPO and the sale of the Private Placement Warrants has been issued by the Company and previously filed as Exhibit 99.1 to a Current Report on Form 8-K on August 13, 2021. The Company’s unaudited pro forma balance sheet as of August 6, 2021, adjusted for the Over-Allotment Closing on August 18, 2021 is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits. The following exhibits are filed with this Form 8-K: